(Q41533306)

English

Regulation of plasma aldosterone levels by metoclopramide: a reappraisal of its mechanism from dopaminergic antagonism to serotonergic agonism

scientific article published on June 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1 reference

Europe PubMed Central

Regulation of plasma aldosterone levels by metoclopramide: a reappraisal of its mechanism from dopaminergic antagonism to serotonergic agonism (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Rizzi CA

1

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Mierau J

2

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Ladinsky H

3

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

publication date

1 June 1997

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

763-768

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Dopaminergic Modulation of Aldosterone Secretion in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Neuropharmacology of emesis induced by anti-cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Interaction of levodopa and metoclopramide on gastric emptying

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Specificity of metoclopramide in assessing the role of dopamine in regulating aldosterone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Effect of Metoclopramide on the Secretion and Metabolism of Aldosterone in Man*

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Effect of a series of 5-HT4 receptor agonists and antagonists on steroid secretion by the adrenal gland in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Effects of ketanserin on cardiovascular, sympatho-adrenal and endocrine systems during physical exercise in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Dopamine modulates sodium-dependent aldosterone responses to angiotensin II in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Blockade of neuronal tryptamine receptors by metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Dopamine regulation of aldosterone secretion: an open question?

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Dopaminergic regulation of aldosterone secretion: How credible?

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Renal and endocrine effects of fenoldopam and metoclopramide in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Renal and neurohumoral effects of ibopamine and metoclopramide in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Metoclopramide fails to stimulate aldosterone secretion and inhibits serotonin-mediated aldosterone secretion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Metoclopramide. An updated review of its pharmacological properties and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

New dopamine receptor agonists in heart failure and hypertension. Implications for future therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Atrial natriuretic factor inhibits metoclopramide stimulated aldosterone release in man

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Lack of effect of the serotonin4 receptor agonist zacopride on ACTH secretion in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

A comparison of the effects of two putative 5-hydroxytryptamine renal prodrugs in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Effect of serotonin on plasma aldosterone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Effect of ketanserin in primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Metoclopramide, domperidone and dopamine in man: actions and interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Dopamine Inhibits Angiotensin-Stimulated Aldosterone Biosynthesis in Bovine Adrenal Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Metoclopramide increases plasma aldosterone concentration in man

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Tonic dopaminergic suppression of plasma aldosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Peripheral serotonin2 receptor blockade does not inhibit 5-hydroxytryptophan-induced aldosterone stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Effects of enhancement and antagonism of 5-hydroxytryptamine activity on metoclopramide-induced aldosterone secretion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Effect of metoclopramide, ondansetron and granisetron on aldosterone secretion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Ketanserin and prazosin: a comparison of antihypertensive and biochemical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Novel enteric 5-HT4 receptors and gastrointestinal prokinetic action

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

The effect of haloperidol on aldosterone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Cloning and expression of human and rat D1 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900025-7

7 January 2021

Identifiers

10.1016/S0028-3908(97)00025-7

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41533306&oldid=1924096565"